CN102228661B - Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis - Google Patents
Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis Download PDFInfo
- Publication number
- CN102228661B CN102228661B CN 201110157185 CN201110157185A CN102228661B CN 102228661 B CN102228661 B CN 102228661B CN 201110157185 CN201110157185 CN 201110157185 CN 201110157185 A CN201110157185 A CN 201110157185A CN 102228661 B CN102228661 B CN 102228661B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- cholecystitis
- mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 201000001352 cholecystitis Diseases 0.000 title claims abstract description 14
- 206010008617 Cholecystitis chronic Diseases 0.000 title claims abstract description 11
- 238000011282 treatment Methods 0.000 title claims description 25
- 241000218176 Corydalis Species 0.000 claims abstract description 9
- 239000004863 Frankincense Substances 0.000 claims abstract description 7
- 241000722953 Akebia Species 0.000 claims abstract description 3
- 239000003814 drug Substances 0.000 claims description 18
- 241000717739 Boswellia sacra Species 0.000 claims description 8
- 241000628997 Flos Species 0.000 claims description 8
- 239000010135 fructus aurantii immaturus Substances 0.000 claims description 6
- 235000014375 Curcuma Nutrition 0.000 claims description 2
- 244000164439 Curcuma angustifolia Species 0.000 claims description 2
- 241000612166 Lysimachia Species 0.000 claims description 2
- 241000545442 Radix Species 0.000 claims description 2
- 241001529553 Scoparia <angiosperm> Species 0.000 claims description 2
- 241001530126 Scrophularia Species 0.000 claims description 2
- 210000000232 gallbladder Anatomy 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 9
- 230000001737 promoting effect Effects 0.000 abstract description 9
- 238000002360 preparation method Methods 0.000 abstract description 5
- 239000008280 blood Substances 0.000 abstract description 4
- 210000004369 blood Anatomy 0.000 abstract description 4
- 230000004087 circulation Effects 0.000 abstract description 4
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 abstract 1
- 235000003097 Artemisia absinthium Nutrition 0.000 abstract 1
- 240000001851 Artemisia dracunculus Species 0.000 abstract 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 abstract 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 abstract 1
- 235000003717 Boswellia sacra Nutrition 0.000 abstract 1
- 235000012035 Boswellia serrata Nutrition 0.000 abstract 1
- 240000007551 Boswellia serrata Species 0.000 abstract 1
- 235000008671 Calycanthus floridus Nutrition 0.000 abstract 1
- 235000008670 Calycanthus occidentalis Nutrition 0.000 abstract 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 abstract 1
- 244000020518 Carthamus tinctorius Species 0.000 abstract 1
- 241000207199 Citrus Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 241000522190 Desmodium Species 0.000 abstract 1
- 241000212322 Levisticum officinale Species 0.000 abstract 1
- 244000148992 Lindera benzoin Species 0.000 abstract 1
- 235000004520 Lindera benzoin Nutrition 0.000 abstract 1
- 235000008262 Lindera benzoin var. benzoin Nutrition 0.000 abstract 1
- 241001673966 Magnolia officinalis Species 0.000 abstract 1
- 235000002226 Ranunculus ficaria Nutrition 0.000 abstract 1
- 244000081426 Ranunculus ficaria Species 0.000 abstract 1
- 244000153955 Reynoutria sachalinensis Species 0.000 abstract 1
- 235000003202 Reynoutria sachalinensis Nutrition 0.000 abstract 1
- 239000001138 artemisia absinthium Substances 0.000 abstract 1
- 235000020971 citrus fruits Nutrition 0.000 abstract 1
- 235000003373 curcuma longa Nutrition 0.000 abstract 1
- 239000001215 curcuma longa l. root Substances 0.000 abstract 1
- 230000006735 deficit Effects 0.000 abstract 1
- 239000001645 levisticum officinale Substances 0.000 abstract 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 abstract 1
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000007788 liquid Substances 0.000 description 8
- 238000005325 percolation Methods 0.000 description 8
- 238000003756 stirring Methods 0.000 description 8
- 238000005406 washing Methods 0.000 description 8
- 238000005303 weighing Methods 0.000 description 7
- 230000006870 function Effects 0.000 description 5
- 239000004280 Sodium formate Substances 0.000 description 4
- 230000006837 decompression Effects 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 238000001914 filtration Methods 0.000 description 4
- 239000012467 final product Substances 0.000 description 4
- 238000003384 imaging method Methods 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000004064 recycling Methods 0.000 description 4
- HLBBKKJFGFRGMU-UHFFFAOYSA-M sodium formate Chemical compound [Na+].[O-]C=O HLBBKKJFGFRGMU-UHFFFAOYSA-M 0.000 description 4
- 235000019254 sodium formate Nutrition 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000010926 purge Methods 0.000 description 3
- 230000000392 somatic effect Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002651 drug therapy Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001314 paroxysmal effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000012285 ultrasound imaging Methods 0.000 description 2
- RUDATBOHQWOJDD-UHFFFAOYSA-N (3beta,5beta,7alpha)-3,7-Dihydroxycholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)CC2 RUDATBOHQWOJDD-UHFFFAOYSA-N 0.000 description 1
- OHXPGWPVLFPUSM-KLRNGDHRSA-N 3,7,12-trioxo-5beta-cholanic acid Chemical compound C1CC(=O)C[C@H]2CC(=O)[C@H]3[C@@H]4CC[C@H]([C@@H](CCC(O)=O)C)[C@@]4(C)C(=O)C[C@@H]3[C@]21C OHXPGWPVLFPUSM-KLRNGDHRSA-N 0.000 description 1
- 208000000197 Acute Cholecystitis Diseases 0.000 description 1
- 206010008614 Cholecystitis acute Diseases 0.000 description 1
- -1 DANTONG Chemical compound 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- YPTFHLJNWSJXKG-UHFFFAOYSA-N Trepibutone Chemical compound CCOC1=CC(OCC)=C(C(=O)CCC(O)=O)C=C1OCC YPTFHLJNWSJXKG-UHFFFAOYSA-N 0.000 description 1
- 238000012084 abdominal surgery Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003591 anti-choleraic effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000731 choleretic agent Substances 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 1
- 229960002997 dehydrocholic acid Drugs 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 208000024557 hepatobiliary disease Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 210000001991 scapula Anatomy 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 229960004974 trepibutone Drugs 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- RUDATBOHQWOJDD-UZVSRGJWSA-N ursodeoxycholic acid Chemical compound C([C@H]1C[C@@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)CC1 RUDATBOHQWOJDD-UZVSRGJWSA-N 0.000 description 1
- 229960001661 ursodiol Drugs 0.000 description 1
- 239000008812 xiaoyanlidan Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese medicinal mixture for treating chronic cholecystitis. Chinese doctors believe that the disease is mainly caused by qi stagnation, moist heat, blood stasis and impairment of yin and is treated on the basis of the principle of purgation and gallbladder soothing, so that the traditional Chinese medicines of giant knotweed, figwort root, akebia stem, szechuan lovage rhizome, desmodium, virgate wormwood herb, turmeric root tuber, safflower, frankincense, officinal magnolia bark, rhizoma corydalis, tangerine peel, citrus peel and combined spicebush root which have the effects of purgating, eliminating heat, soothing liver-gallbladder, promoting the circulation of qi and relieving pain are carefully selected and are prepared into the mixture in a preparation room of the hospital of the inventor to be taken by a patient. Clinical tests show that the total effectiveness ratio is 96.7 percent; and the mixture has quick response and low cost and is worthy of wide clinical application.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, relate in particular to a kind of Chinese medicine composition for the treatment of chronic cholecystitis.
Background technology
Chronic cholecystitis is one of clinical modal hepatobiliary system disease.Modern medicine thinks that primary disease is that the chronic inflammatory disease of gallbladder sexually revises, and is the result that acute cholecystitis is repeatedly shown effect.The patient has the greasy phenomenon of flatulence, belch and anorexia usually, often feels epigastric discomfort after being satiated with food, and can ease the pain after food unlike duodenal ulcer.The normal sense of patient has under the right scapula, under the right season rib or right waist etc. locate dull pain, stand, more obvious after motion or the psychrolusia.Because often dull pain is uncomfortable, patient's little motion, body weight often alleviates to some extent.In case when because of the calculus incarceration acute attack being arranged, upper right abdomen will have frequent dull pain, and the paroxysmal aggravation is arranged, the visible thickening of capsule wall of gallbladder of imaging examination, gallbladder contraction function is poor.
At present, the main Drug therapy of method and the operative treatment for the treatment of chronic cholecystitis, Drug therapy mainly is the method for anti-inflammatory and choleretic, such as XIAOYAN LIDAN PIAN, phenylpropanol-yichang, trepibutone, DANTONG, dehydrocholic acid and ursodeoxycholic acid etc., some patient is effective, but relapse rate is high, and therapeutic effect is undesirable; The operative treatment cholecystitis be one of modal operation of present abdominal surgery, but also there is drawback in operative treatment, and namely wound is large, and postoperative easily produces complication.
Summary of the invention
The purpose of this invention is to provide a kind of herb mixture for the treatment of chronic cholecystitis, the traditional Chinese medical science thinks that the stagnation of QI, damp and hot, blood stasis, the cloudy wound are to cause this sick reason, and treatment is take the purging FU-organs function of gallbladder promoting as principle, should eliminating heat pathogen by purging the bowels to reach, and depressed liver-energy dispersing and function of gallbladder promoting, the purpose of promoting the circulation of QI to relieve pain.
The objective of the invention is to be achieved through the following technical solutions, the Chinese medicine gallbladder health-care composition of this treatment chronic cholecystitis is made by the Chinese medicine of following weight portion: Rhizoma Polygoni Cuspidati 7-12 part, Radix Scrophulariae 7-9 part, Caulis Akebiae 10-15 part, Rhizoma Chuanxiong 7-9 part, Herba Lysimachiae 10-15 part, Herba Artemisiae Scopariae 9-12 part, Radix Curcumae 9-12 part, Flos Carthami 7-11 part, Olibanum 7-11 part, Cortex Magnoliae Officinalis 9-12 part, Rhizoma Corydalis 10-15 part, Pericarpium Citri Reticulatae 9-11 part, Fructus Aurantii Immaturus 7-9 part, Radix Linderae 5-8 part.
Preferably, the Chinese medicine gallbladder health-care composition of this treatment chronic cholecystitis is made by the Chinese medicine of following weight portion: 9 parts of Rhizoma Polygoni Cuspidati, 8 parts of Radix Scrophulariaes, 12 parts of Caulis Akebiaes, 8 parts of Rhizoma Chuanxiongs, 13 parts of Herba Lysimachiaes, 10 parts of Herba Artemisiae Scopariaes, 10 parts of Radix Curcumaes, 9 parts on Flos Carthami, 9 parts of Olibanums, 11 parts of Cortex Magnoliae Officinalis, 13 parts of Rhizoma Corydalis, 10 parts of Pericarpium Citri Reticulataes, 8 parts of Fructus Aurantii Immaturuss, 6 parts of the Radixs Linderae.
Preparation method:
Take by weighing in proportion above each medicine, be ground into coarse powder, connect percolation, make solvent with 57% ethanol, flood after 24 hours, with about 1 milliliter the speed percolation slowly of per minute, filter approximately 700 milliliters of liquid of collection, decompression recycling ethanol, and be concentrated into approximately 170 milliliters, take out, add 200 milliliters in water, boiled 30 minutes, left standstill 48 hours, filter, a small amount of water washing of filtering residue, washing liquid is incorporated in the filtrate, be evaporated to approximately 180 milliliters, add stupid sodium formate 1.5 grams, stir evenly, left standstill 24 hours, filter, add 250 milliliters in water, stir evenly, and get final product.
Rhizoma Polygoni Cuspidati, Radix Scrophulariae, Caulis Akebiae, Rhizoma Chuanxiong eliminating heat pathogen by purging the bowels in the side; Herba Lysimachiae Herba Artemisiae Scopariae, Radix Curcumae depressed liver-energy dispersing and function of gallbladder promoting; Flos Carthami, Olibanum blood circulation promoting and blood stasis dispelling; Cortex Magnoliae Officinalis, Rhizoma Corydalis, Pericarpium Citri Reticulatae, Fructus Aurantii Immaturus, Radix Linderae promoting the circulation of QI to relieve pain; All medicines share, altogether the effect of long memorial liver function of gallbladder promoting, heat clearing away circulation of qi promoting, anti-inflammatory analgetic.
Clinical data
1, whole 120 examples of physical data are Digestive System Department out-patient to our hospital, are divided at random 2 groups.Treatment group 60 examples, male 37 examples, women 23 examples: age 18-80 year, average (46 ± 8.5) year; The course of disease 5 months～28 years; Matched group 60 examples, male 31 examples, women 29 examples: 19～81 years old age, average (45 ± 7.8) year; The course of disease 6 months～29 years.2 groups of case physical data comparing difference not statistically significants (P＞0.05) have comparability.
2, the diagnostic criteria Standards of Chinese Medical Syndrome Differentiation adopts the standard of Ministry of Public Health " new Chinese medicine guideline of clinical investigations " formulation.Syndrome of stagnation of QI: the frequent pain of right rib abdominal part, or the paroxysmal aggravation is arranged, and pain is drawn the shoulder back of the body, bitter taste, and inappetence, upper right abdomen has mild tenderness, and body of the tongue is light red, tongue fur white or little Huang, stringy and thready pulse or stringy and tense pulse.Syndrome of blood stasis: twinge is arranged during right rib abdominal part, and sore spot is fixing not to be moved, under the rib or long-pending piece is arranged, and the complexion sooting, lip is purple dark, red tongue or ecchymosis is arranged, tongue fur is white, deep pulse or puckery.
3, the Therapeutic Method treatment group is taken Chinese medicine gallbladder health-care composition, every day 3 times, each 50 milliliters; Matched group is taken cefalexin capsule (Harbin Pharmaceutical Group three smart pharmaceutcal corporation, Ltds produce), and is each 0.25, every day 3 times.Two groups equal 10 days be a course for the treatment of, observe the curative effect after two courses for the treatment of, viewing duration is withdrawn other drug.
4, criterion of therapeutical effect is determined curative effect with reference to " new Chinese medicine guideline of clinical investigations ".Clinical recovery: symptom, somatic feature score reduce＞95%, and image check is normal: produce effects: symptom, somatic feature score reduce＞70%, and imaging examination meets the produce effects standard; Effectively: symptom, integration reduce＞30%, and imaging examination reaches effective standard; Invalid: symptom, somatic feature score reduce＜30%, and imaging examination is all without improving.
5, therapeutic outcome
Clinical efficacy comparison sees Table one before and after (1) two group for the treatment of
Table 1 liang group curative effect statistics
The total effective rate for the treatment of group is 96.7%, and matched group is that 78.3%, two group of total effective rate comparing difference has statistical significance P＜0.01).
Gall bladder B mode ultrasound imaging checks that integration change situation sees Table two before and after (2) two groups of treatments
Gall bladder B mode ultrasound imaging integral contrast before and after the table 2 liang group treatment (X ± S)
Ultrasound diagnosis integration no significant difference (P＞0.05) before two groups of treatments.After the treatment, two groups of integrations all significantly descend.Before and after two groups of treatments differences relatively, difference has significant (P＜0.01), illustrates that treatment group improves the curative effect of gallbladder contraction function and pathological change and be better than matched group.
The specific embodiment
Embodiment one: take by weighing Rhizoma Polygoni Cuspidati 9g, Radix Scrophulariae 8g, Caulis Akebiae 12g, Rhizoma Chuanxiong 8g, Herba Lysimachiae 13g, Herba Artemisiae Scopariae 10g, Radix Curcumae 10g, Flos Carthami 9g, Olibanum 9g, Cortex Magnoliae Officinalis 11g, Rhizoma Corydalis 13g, Pericarpium Citri Reticulatae 10g, Fructus Aurantii Immaturus 8g, Radix Linderae 6g.Preparation method: take by weighing in proportion above each medicine, be ground into coarse powder, connect percolation, make solvent with 57% ethanol, flood after 24 hours, with about 1 milliliter the speed percolation slowly of per minute, filter approximately 700 milliliters of liquid of collection, decompression recycling ethanol, and be concentrated into approximately 170 milliliters, take out, add 200 milliliters in water, boiled 30 minutes, left standstill 48 hours, filter, a small amount of water washing of filtering residue, washing liquid is incorporated in the filtrate, be evaporated to approximately 180 milliliters, add stupid sodium formate 1.5 grams, stir evenly, left standstill 24 hours, filter, add 250 milliliters in water, stir evenly, and get final product.
Embodiment two: take by weighing Rhizoma Polygoni Cuspidati 12g, Radix Scrophulariae 7g, Caulis Akebiae 15g, Rhizoma Chuanxiong 7g, Herba Lysimachiae 10g, Herba Artemisiae Scopariae 9g, Radix Curcumae 12g, Flos Carthami 7g, Olibanum 11g, Cortex Magnoliae Officinalis 12g, Rhizoma Corydalis 10g, Pericarpium Citri Reticulatae 11g, Fructus Aurantii Immaturus 7g, Radix Linderae 8g.Preparation method: take by weighing in proportion above each medicine, be ground into coarse powder, connect percolation, make solvent with 57% ethanol, flood after 24 hours, with about 1 milliliter the speed percolation slowly of per minute, filter approximately 700 milliliters of liquid of collection, decompression recycling ethanol, and be concentrated into approximately 180 milliliters, take out, add 250 milliliters in water, boiled 30 minutes, left standstill 48 hours, filter, a small amount of water washing of filtering residue, washing liquid is incorporated in the filtrate, be evaporated to approximately 200 milliliters, add stupid sodium formate 1.5 grams, stir evenly, left standstill 24 hours, filter, add 220 milliliters in water, stir evenly, and get final product.
Embodiment three: take by weighing Rhizoma Polygoni Cuspidati 7g, Radix Scrophulariae 9g, Caulis Akebiae 10g, Rhizoma Chuanxiong 9g, Herba Lysimachiae 15g, Herba Artemisiae Scopariae 12g, Radix Curcumae 9g, Flos Carthami 11g, Olibanum 7g, Cortex Magnoliae Officinalis 9g, Rhizoma Corydalis 15g, Pericarpium Citri Reticulatae 9g, Fructus Aurantii Immaturus 9g, Radix Linderae 5g.Preparation method: take by weighing in proportion above each medicine, be ground into coarse powder, connect percolation, make solvent with 57% ethanol, flood after 24 hours, with about 1 milliliter the speed percolation slowly of per minute, filter approximately 700 milliliters of liquid of collection, decompression recycling ethanol, and be concentrated into approximately 160 milliliters, take out, add 220 milliliters in water, boiled 30 minutes, left standstill 48 hours, filter, a small amount of water washing of filtering residue, washing liquid is incorporated in the filtrate, be evaporated to approximately 190 milliliters, add stupid sodium formate 1.5 grams, stir evenly, left standstill 24 hours, filter, add 210 milliliters in water, stir evenly, and get final product.
Claims (2)
1. herb mixture for the treatment of chronic cholecystitis is characterized in that this controls herb mixture and made by the Chinese medicine of following weight portion: Rhizoma Polygoni Cuspidati 7-12 part, Radix Scrophulariae 7-9 part, Caulis Akebiae 10-15 part, Rhizoma Chuanxiong 7-9 part, Herba Lysimachiae 10-15 part, Herba Artemisiae Scopariae 9-12 part, Radix Curcumae 9-12 part, Flos Carthami 7-11 part, Olibanum 7-11 part, Cortex Magnoliae Officinalis 9-12 part, Rhizoma Corydalis 10-15 part, Pericarpium Citri Reticulatae 9-11 part, Fructus Aurantii Immaturus 7-9 part, Radix Linderae 5-8 part.
2. a kind of herb mixture for the treatment of chronic cholecystitis according to claim 1 is characterized in that this herb mixture made by the Chinese medicine of following weight portion: 9 parts of Rhizoma Polygoni Cuspidati, 8 parts of Radix Scrophulariaes, 12 parts of Caulis Akebiaes, 8 parts of Rhizoma Chuanxiongs, 13 parts of Herba Lysimachiaes, 10 parts of Herba Artemisiae Scopariaes, 10 parts of Radix Curcumaes, 9 parts on Flos Carthami, 9 parts of Olibanums, 11 parts of Cortex Magnoliae Officinalis, 13 parts of Rhizoma Corydalis, 10 parts of Pericarpium Citri Reticulataes, 8 parts of Fructus Aurantii Immaturuss, 6 parts of the Radixs Linderae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110157185 CN102228661B (en) | 2011-05-31 | 2011-05-31 | Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110157185 CN102228661B (en) | 2011-05-31 | 2011-05-31 | Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102228661A CN102228661A (en) | 2011-11-02 |
| CN102228661B true CN102228661B (en) | 2013-01-30 |
Family
ID=44841293
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110157185 Expired - Fee Related CN102228661B (en) | 2011-05-31 | 2011-05-31 | Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102228661B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103656512A (en) * | 2013-12-13 | 2014-03-26 | 青岛友铭辰生物技术有限公司 | Traditional Chinese medicinal grains for treating cholecystitis and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1127128A (en) * | 1995-09-14 | 1996-07-24 | 隋嫣玲 | Traditional Chinese medicine for cholelithiasis and preparing method |
| CN101843882A (en) * | 2009-11-05 | 2010-09-29 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating cholecystitis diseases and preparation method thereof |
| CN101850086A (en) * | 2009-11-05 | 2010-10-06 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating symptom of gallstones and preparation method thereof |
-
2011
- 2011-05-31 CN CN 201110157185 patent/CN102228661B/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1127128A (en) * | 1995-09-14 | 1996-07-24 | 隋嫣玲 | Traditional Chinese medicine for cholelithiasis and preparing method |
| CN101843882A (en) * | 2009-11-05 | 2010-09-29 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating cholecystitis diseases and preparation method thereof |
| CN101850086A (en) * | 2009-11-05 | 2010-10-06 | 泰一和浦（北京）中医药研究院有限公司 | Chinese medicinal composition for treating symptom of gallstones and preparation method thereof |
Non-Patent Citations (5)
| Title |
|---|
| 周国亮.古代治疗黄疸方剂源流及用药规律研究.《中国优秀硕士学位论文全文数据库》.2011,全文. * |
| 江晁佑.唐代御撰方书黄疸病证治探讨.《中国优秀硕士学位论文全文数据库》.2005,全文. * |
| 王光辉 * |
| 王琦 * |
| 袁伟.常见肝胆病证的中医诊断及治疗.《社区医学杂志》.2006,第4卷(第9期),4-8. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102228661A (en) | 2011-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102579774B (en) | Traditional Chinese medicine composition for treating tuberculosis of cervical lymph nodes | |
| CN101961449B (en) | Traditional Chinese medicine for treating tinea corporis | |
| CN103301400A (en) | Traditional Chinese medicinal composition for treating chronic atrophic gastritis and preparation method of traditional Chinese medicinal composition | |
| CN102319397A (en) | Chinese medicinal decoction for treating chronic pelvic inflammatory disease with clystering method | |
| CN102266422A (en) | Chinese medicinal preparation for treating slight and severe chilblains and production method thereof | |
| CN105641564A (en) | Medicine for treating gouty arthritis by combining oral administration and external application of traditional Chinese medicines | |
| CN103961587A (en) | Traditional Chinese medicinal preparation for treating radiographic contrast nephropathy and preparation method thereof | |
| CN102228661B (en) | Chinese medicinal cholecystitis treatment mixture for treating chronic cholecystitis | |
| CN105125792A (en) | Traditional Chinese medicinal decoction for treating female mastitis and preparation method of decoction | |
| CN104689132A (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN102935215B (en) | Traditional Chinese medicinal composition for treating acute cholecystitis | |
| CN1284593C (en) | Medicine for treating anaphylactoid purpura | |
| CN105233078A (en) | Traditional Chinese medicine composition for treating viral hepatitis | |
| CN105125814B (en) | It is a kind of to treat chronic renal failure III, the Chinese medicine composition of IV phase | |
| CN104383376A (en) | Traditional Chinese medicinal composition for treating woman vulva squamous epithelial cell proliferation | |
| CN102430066B (en) | Sciatic nerve liquid | |
| CN103536851A (en) | Traditional Chinese medicine composition for treating alcoholic fatty liver | |
| CN103432333B (en) | Composition consisting of effective traditional Chinese medicine parts and used for treating hypothyroidism | |
| CN102836346B (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
| CN100406035C (en) | Chinese medicine preparation for treating protrasion of lumbar intervertebral disc | |
| CN105381177A (en) | External use traditional Chinese medicine for treating sweet stains | |
| CN105521026A (en) | Injection for treating epidemic cerebrospinal meningitis | |
| CN101979040B (en) | Medicament for treating central serous chorioretinopathy | |
| CN104055979A (en) | Chinese herb preparation for treating liver and gall damp-heat type chronic pancreatitis | |
| CN104096112A (en) | Traditional Chinese medicine composition for treating angina pectoris |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130130 Termination date: 20130531 |